Comparison of intracranial infusions of colchirine and ibotenic acid as models of neurodegeneration in the basal forebrain

doi:10.1016/0006-8993(94)91212-2

Brain Research

Volume 637, Issues 1–2, 21 February 1994, Pages 15-26

https://doi.org/10.1016/0006-8993(94)91212-2 Get rights and content

Abstract

Colchicine and ibotenic acid were compared for their ability to produce neurodegeneration and cognitive deficit after bilateral infusions into the nucleus basalis magnocellularis of male Long-Evans rats. Four weeks post-lesion, there was no difference in locomotor activity following infusion of either neurotoxicant or vehicle. In a passive avoidance task, both treated groups had significantly shorter step-through latencies compated with vehicle. Five weeks post-lesion, rats were killed for neurochemistry or histochemistry. Choline acetyltransferase (ChAT) activity in both the frontal and parietal cortex was significantly decreased (25–35%) in the colchicine- and ibotenic acid-infused rats when compared to control. There was no effect of either neurotoxicant on ChAT activity in the hippocampus or striatum. Both neurotoxicants produced damage in the general area of the ventromedial pallidum, although ibotenic acid infusion consistently produced a larger area of damage as assessed in Nissl-stained sections. Analysis of the number of ChAT-immunoreactive cells in the nucleus basalis magnocellularis (NBM) showed an average 60% cell loss following colchicine infusion and a 75% cell loss after ibotenic acid infusion. Area of glutamic acid decar☐ylase (GAD) staining was significantly decreased in several regions surrounding the NBM for ibotenic acid (51% average decrease), and showed non-significant decreases (28%) following colchicine infusion. Colchicine infusion decreased dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum; ibotenic acid had no effect on brain catechol or indoleamine levels. The results indicate that although similar cholinergic hypofunction and behavioral deficits were achieved, several non-cholinergic differences between the neurotoxicants were detected.

Reference (55)

BaroneS. et al.
The neurobiological effects of colchicine: modulation by nerve growth factor
Brain Res. Bull.
(1992)
BartusR.T. et al.
Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies
Pharm. Biochem. Behav.
(1985)
BradfordM.
A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
Anal. Biochem.
(1976)
ConnorD.J. et al.
Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid
Brain Res.
(1991)
CroftonK.M. et al.
Interlaboratory comparison of motor activity experiments: implications for neurotoxicological assessments
Neurotoxicol. Teratol.
(1991)
DasheiffR.M. et al.
The effects of colchicine in mammalian brain from rodents to monkeys
Brain Res. Rev.
(1985)
DekkerA.J.A.M. et al.
The role of cholinergic projections from the nucleus basalis in memory
Neurosci. Biobehav. Rev.
(1991)
Di PatreP.L. et al.
GM1 ganglioside counteracts cholinergic and behavioral deficits induced in the rat by intracerebral injection of vincristine
Eur. J. Pharm.
(1989)
FibigerH.C. et al.
Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection
Pharm. Biochem. Behav.
(1974)
FibigerH.C.
The organization and some projections of cholinergic neurons of the mammalian forebrain
Brain Res. Rev.
(1982)

FlickerC. et al.

Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat

Pharm. Biochem. Behav.

(1983)

FriedmanE. et al.

Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning

Pharma. Biochem. Behav.

(1983)

GaykemaR.P.A. et al.

Cholinergic fiber aberrations in nucleus basalis rat and Alzheimer's disease

Neurobiol. Aging

(1992)

GinnS.R. et al.

Studies related to the use of colchicine as a neurotoxin in the septohippocampal cholinergic system

Brain Res.

(1992)

HaroutunianV. et al.

Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats

Brain Res.

(1990)

KellyJ. et al.

Behavioral and biochemical effects of knife cuts that preferentially interrupt principle afferent and efferent connections of the striatum in the rat

Pharm. Biochem. Behav.

(1977)

LothmanE.W. et al.

Potential mechanisms underlying the destruction of dentate gyrus granule cells by colchicine

Exp. Neurol.

(1982)

LowryO.H. et al.

Protein measurement with folin-phenol reagent

J. Biol. Chem.

(1951)

MarkowskaA.L. et al.

Nucleus basalis magnocellularis and memory: differential effects of two neurotoxins

Behav. Neural. Biol.

(1990)

MiyamotoM. et al.

Characteristics of memory impairment following lesioning of the basal forebrain and medial septal neucleus in rats

Brain Res.

(1987)

MundyW.R. et al.

Neurotoxic lesions of the nucleus basalis induced by colchicine: effects on spatial navigation in the water maze

Brain Res.

(1990)

NitschC. et al.

Calcium deposits develop in rat substantia nigra but not striatum several weeks after local ibotenic acid injection

Brain Res. Bull.

(1990)

OertelW.H. et al.

Production of a specific antiserum to rat brain glutamic acid decar☐ylase by injection of an antigen-antibody complex

Neuroscience

(1981)

PetersonG.M. et al.

Direct neurotoxic effects of colchicine on cholinergic neurons in medial septum and striatum

Neurosci. Lett.

(1988)

RiekkinenM. et al.

Comparison of quisqualic and ibotenic acid nuclear basalis magnocellularis lesions on water-maze and passive avoidance performance

Brain Res. Bull.

(1991)

RobbinsT.W. et al.

Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes

Behav. Brain Res.

(1989)

SmithG.

Animal models of Alzheimer's disease: experimental cholinergic denervation

Brain Res. Rev.

(1988)

Cited by (19)

Cognitive Function
2010, Comprehensive Toxicology, Second Edition
Neurotoxicity in humans involves chemical-induced alterations in motor, sensory, emotional, personality, and cognitive functions. Alterations in cognitive function include changes in learning, mathematical abilities, categorization, coding, concept shifting, distractibility, memory, pattern recognition, reading, spatial relations, sustained and selective attention, vocabulary, and intelligence. Considerable effort has been made to characterize effects of chemicals on cognitive functions using animal models. Information from these models has been used to develop strategies to identify chemicals that are likely to affect these functions in humans, to determine the cellular targets of centrally acting neurotoxicants, to characterize pathways by which effects at these targets lead to cognitive dysfunction, and thereby to improve our understanding of the neurobiological underpinnings of cognition. This chapter (a) provides working definitions of cognitive functions, such as learning, memory, and attention; (b) presents an overview of some of the procedures commonly used in behavioral toxicology to assess the effects of chemicals on cognitive function in animals; and (c) discusses some critical experimental and conceptual variables that are important for studies on chemical-induced cognitive dysfunction.
A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models
2005, Brain Research
Citation Excerpt :
Therefore, it is a model suitable for pharmacological studies of drug effects on memory deficits. The model induced by Ibot A alone is also widely used for the study of drug effects on memory deficit [1,5,46]. The results of this paper revealed some similar drug effects in this model as in the other two models.
The purpose of this paper is to study the basic pharmacological action of sarsasapogenin, a sapogenin from the Chinese medicinal herb Rhizoma Anemarrhenae, (abbreviated as ZMS in this paper), on learning ability and memory of three animal models: aged rats and two neurodegeneration models produced either by single unilateral injection of beta-amyloid 1–40 (Aβ_1–40) plus ibotenic acid (Ibot A) or by bilateral injection of Ibot A alone into nucleus basalis magnocellularis. Y-maze test and step-through test revealed that learning ability and memory were impaired in the three models and were improved by oral administration of ZMS. ZMS did not inhibit acetylcholinesterase nor did it occupy the binding sites of muscarinic acetylcholine receptor (M receptor), hence it is neither an cholinesterase inhibitor nor an agonist or antagonist of M receptors. On the other hand, the densities of total M receptor and its M₁ subtype in the brain of the three models were significantly lower than control rats, and ZMS significantly raised the densities of total M receptors and its M₁ subtype. Linear regression revealed significant correlation between the learning ability/memory and the density of either total M receptor or its M₁ subtype. Autoradiographic study with ³H-pirenzipine showed that the M₁ subtype density was significantly lowered in cortex, hippocampus and striatum of aged rats, and ZMS could reverse these changes towards normal control level. Interestingly, the M₁ receptor density after ZMS administration only approached but did not exceed that of normal young control rats. Therefore, ZMS seems to represent a new approach to the pharmacological regulation of learning and memory and appears to be not simply palliative but may modify the progression of the disease.
Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated Alzheimer's disease model
2004, Neuroscience
It has been implicated that glia activation plays a critical role in the progression of Alzheimer's disease (AD). However, the precise mechanism of glia activation is not clearly understood yet. In our present studies, we confirmed our previous results where change the levels of neuropeptides and peptidases in ibotenic acid (IBO) infusion into the rat nucleus basalis magnocellularis, an animal model of AD. Furthermore, we extended our study to investigate a possible protection effect of co-administration on the changes of neuropeptides, and neuronal and glial cells in IBO-infused rat brain by memantine treatment. The levels of substance P and somatostatin were decreased in the striatum and frontal cortex 1 week after IBO infusion, and recovered to the control level by memantine treatment, indicating the involvement of neuropeptides in AD pathology. Furthermore, the immunohistochemical and enzymatic studies of GFAP and CD 11b, and peptidylarginine deiminase, markers of glia, in the striatum and frontal cortex showed the increase in IBO-treated rat brain as compared with controls, while co-administration of memantine and IBO no increase of astrocytes and microglia activation was observed. The present biochemical and immunohistochemical results suggest that glia activation might play an important role to the pathology of AD, and correlate with the changes of neuropeptide levels in AD brain that is recovered by memantine treatment.
Neuroprotection and aging of the cholinergic system: A role for the ergoline derivative nicergoline (Sermion®)
2002, Neuroscience
The aging brain is characterized by selective neurochemical changes involving several neural populations. A deficit in the cholinergic system of the basal forebrain is thought to contribute to the development of cognitive symptoms of dementia. Attempts to prevent age-associated cholinergic vulnerability and deterioration therefore represent a crucial point for pharmacotherapy in the elderly. In this paper we provide evidence for the protective effect of nicergoline (Sermion^®) on the degeneration of cholinergic neurons induced by nerve growth factor deprivation. Nerve growth factor deprivation was induced by colchicine administration in rats 13 and 18 months old. Colchicine induces a rapid and substantial down-regulation of choline acetyltransferase messenger RNA level in the basal forebrain in untreated adult, middle-aged and old rats. Colchicine failed to cause these effects in old rats treated for 120 days with nicergoline 10 mg/kg/day, orally. Moreover, a concomitant increase of both nerve growth factor and brain-derived neurotrophic factor content was measured in the basal forebrain of old, nicergoline-treated rats. Additionally, the level of messenger RNA for the brain isoform of nitric oxide synthase in neurons of the basal forebrain was also increased in these animals.
Based on the present findings, nicergoline proved to be an effective drug for preventing neuronal vulnerability due to experimentally induced nerve growth factor deprivation.
Dissociation between the attentional functions mediated via basal forebrain cholinergic and GABAergic neurons
2001, Neuroscience
The role of basal forebrain corticopetal cholinergic projections in attentional functions has been extensively investigated. For example, 192 IgG-saporin-induced loss of cortical cholinergic inputs was repeatedly demonstrated to result in a selective impairment in the ability of rats to detect signals in a task designed to assess sustained attention performance. The loss of cortical cholinergic inputs correlated highly with the decrease in the hit rate. Little is known about the functions of basal forebrain non-cholinergic neurons, particularly corticopetal GABAergic neurons, largely because of the absence of specific research tools to manipulate selectively this projection. As basal forebrain lesions produced with ibotenic acid were previously observed to potently destroy non-cholinergic, particularly GABAergic neurons while producing only moderate decreases in the density of cortical cholinergic inputs, the present experiment examined the effects of such lesions on sustained attention performance and then compared these effects with the immunohistochemical and attentional consequences of selective cholinotoxic lesions produced by intra-basal forebrain infusions of 192 IgG-saporin. In contrast to the selective decrease in hits previously observed in 192 IgG-saporin-lesioned animals, the attentional performance of ibotenic acid-lesioned animals was characterized by a selective increase in the relative number of false alarms, that is ‘claims’ for signals in non-signal trials. Analyses of the response latencies suggested that this effect of ibotenic acid was due to impairments in the animals’ ability to switch from the processing of the response rules for signal trials to those for non-signal trials. As expected, 192 IgG-saporin did not affect the number of basal forebrain parvalbumin-positive neurons, that are presumably GABAergic, but decreased cortical acetylcholinesterase-positive fiber density by over 80%. Conversely, in ibotenic acid-lesioned animals, basal forebrain parvalbumin-positive cells were decreased by 60% but cortical acetylcholinesterase-positive fiber density was only moderately reduced (less than 25%).
These data form the basis for the development of the hypothesis that basal forebrain GABAergic neurons mediate executive aspects of attentional task performance. Such a function may be mediated in parallel via basal forebrain GABAergic projections to the cortex and the subthalamic nucleus.
Time course of changes in cholinergic and neurotrophin-related markers after infusion of colchicine into the basal forebrain
1998, Brain Research
After bilateral infusions of colchicine or vehicle in the rat nucleus basalis magnocellularis, the time course of changes in several cholinergic and neurotrophin-related markers were assessed. Animals were sacrificed at 3, 7, 14, 28, 35 and 84 days post-lesion, and both the NBM and cortical areas were assessed. Sections were stained immunohistochemically for choline acetyltransferase (ChAT) or p140^trk (trk) or histochemically for acetylcholinesterase (AChE). ChAT activity and neurotrophin protein levels were assessed regionally. The number of ChAT immunoreactive NBM neuronal profiles decreased beginning 3 days post-lesion and reach maximal loss by 28 days post-lesion, with no recovery. Examination of trk-IR around the NBM revealed a time-dependent decrease in trk-IR of magnocellular neurons and an increase in trk-IR of astrocytes at 14 and 28 days post-lesion. The density of AChE-stained cortical fibers was maximally decreased 3 days post-lesion followed by an increase in fiber staining across the remaining time points. Cortical ChAT activity showed the largest decrease at 7 days followed by recovery 84 days after colchicine infusion. There was an increase in NGF in the parietal cortex after colchicine infusion but no change in BDNF level. These patterns of changes in the cholinergic and neurotrophin-related markers suggest an association between NGF and lesion-induced compensatory responses in the basal forebrain cholinergic system.

View all citing articles on Scopus

View full text

Comparison of intracranial infusions of colchirine and ibotenic acid as models of neurodegeneration in the basal forebrain

Abstract

Brain Res. Bull.

Pharm. Biochem. Behav.

Anal. Biochem.

Brain Res.

Neurotoxicol. Teratol.

Brain Res. Rev.

Neurosci. Biobehav. Rev.

Eur. J. Pharm.

Pharm. Biochem. Behav.

Brain Res. Rev.

Pharm. Biochem. Behav.

Pharma. Biochem. Behav.

Neurobiol. Aging

Brain Res.

Brain Res.

Pharm. Biochem. Behav.

Exp. Neurol.

J. Biol. Chem.

Behav. Neural. Biol.

Brain Res.

Brain Res.

Brain Res. Bull.

Neuroscience

Neurosci. Lett.

Brain Res. Bull.

Behav. Brain Res.

Brain Res. Rev.